Human histocompatibility leukocyte antigen (HLA)-DM is a facilitator of antigen presentation via major hlstocompatibility complex (MHC) class II molecules. In the absence of HLA-DM, MHC class II molecules do not present natural peptides, but tend to remain associated with class II-associated invariant chain peptides (CLIP). Recently, DM was shown to catalyze the release of CLIP from HLA-DR. We have investigated which peptides bound to HLA-DR are vulnerable to release upon encountering DM. By directed substitution of allele-specific anchor residues between CLIP and DR3-cognate peptldes and the application of recombinant DM we show that DM catalyzes the release of those peptides bound to HLA-DR3 that do not have appropriate anchor residues and, hence, no optimal ligand binding motif. Thus, HLA-DM acts as a peptide editor, facilitating selection of peptides that stably bind to class II molecules for eventual presentation to the immune system from the pool of available peptides.
M
HC class II molecules are heterodimeric transmembrane glycoproteins that present peptides to CD4 Th cells (1, 2) . HLA-DR, a prototype class II molecule, usually presents peptides derived from exogenous sources. After assembly of the MHC class II ot[~ dimers in the endoplasmic reticulum (ER), the complex associates with the invariant chain (Ii) (3) . Subsequently, the ci[3-Ii complex is targeted to specialized antigen-processing (MIIC) vesicles that contain antigens gathered by endocytosis (4, 5) . Ii is sequentially degraded, allowing class II molecules to bind exogenous peptides in the MIICs. One of the final biosynthetic intermediates in the degradation of Ii is the complex between oti3DlZL and class II-associated invariant chain peptide (CLIP), which represents a nested set of Ii-derived peptides that bind in the groove of the class II complex. In vitro experiments show that release of CLIP requires an acidic pH, which is a feature of endocytic compartments in vivo (6) (7) (8) .
In cell lines mutated for the MHC-encoded HLA-DM molecule, however, DR3 remains mainly complexed to CLIP, indicating failure to release this Ii peptide. Similarly, in transgenic mice lacking H2-M, the murine equivalent of HLA-DM, the majority of the class II molecules is bound to CLIP (9, 10) . DM is a nonpolymorphic, 0~-heterodimeric complex located in MIIC compartments (11) (12) (13) (14) (15) (16) . P,.ecently, DM was shown in vitro to catalyze the dissociation of CLIP from DR3 (17) (18) (19) . Thus, DM seems to facilitate the generation of DR complexes that can accommodate antigenic peptides. Besides CLIP, DM is able to release some but not aH antigenic peptides from class II molecules (17) . We set out to determine which peptide-DR complexes are preferential substrates for the catalytic action of HLA-DM and which factors determine this process. We demonstrate that DM functions as a general catalyst for peptide release from DR. The composition of the bound peptide is the crucial factor determining which peptides can be released from the class II complex upon encountering DM.
Materials and Methods
Cell Lines and Culture Conditions. The B × T hybnd cell line T2.DR3, a stable derivative of the T2 cell line transfected with HLA-DR3, was kindly provided by P. Cresswell (20) and maintamed in IKPMI supplemented with 5°6, fetal calf serum and 500 ~g/rnl G418 (Sigma, Poole, UK). Sf9 cells (PharMmgen, San Diego, CA) were grown In suspension in Grace's medmm (Imperial Laboratories, London, UK) supplemented with 10% fetal calf serum, 1% Amphotencin B (Sigma), and 50 la, g/ml Gentamycm (Sigma) at 37°C. mAbs and Peptides. mAb L243 (American Type Culture Collection, P,.ockv]lle, MD) binds to a nonpolymorphic determinant present on HLA-DR molecules, mAb 5CI was raised against the c(1 and 0t2 domains of DMcx as described before (21) . The DM[3-specific anuserum FS4 was raised by F. Sanderson (Imperial Cancer Research Fund, London, UK) by immunizing rabbits with recombinant DM[3 protein expressed in bacteria. His-tag--specific mAb was obtained from Daanova. (Table 1) were synthesized on a multiple pepnde synthesiser (SMPS 350, Zinsser Analytic, Frankfurt/M, Germany) using Fmoc/tBu strategy and Wang resin (p-benzyloxybenzylalcohol-polystyrene). NH2-termmal biotinylation was conducted during synthesis and pepudes were checked for purity and structure as descnbed (25) .
Production and Purification of HLA-DM and HLA-DR. Truncated genes coding for soluble DMci and DM[3 chains lacking the transmembrane and the cytosolic regions were generated by polymerase chain reaction. The genes were truncated after codons 244 (DMA) and 274 (DMB) of the original eDNA sequences (13) and a hexa-histidine tag (His-tag) was genetically attached to the novel C O O H terminus of the DMI3 chain. The constructs were cloned into the dual promoter transfer vector pBacp10pol (22) and recombinant baculoviruses were produced using BaculoGold D N A (PharMlngen). sDM was produced using Sf9 cells in protein-free medium (PharMmgen) to prevent aggregation of the recombinant protein, sDM was purified by atiqmt T chromatography via the His-tag using T A L O N metal affinity resin (Clontech, Palo Alto, CA) in the presence of 1% detergent (C12Ev or NP-40). The complex was eluted using a gradient of(1-100 mM mfidazole in PBS, pH 8.(I.
HLA-DR3 molecules were purified from T2.DR3 cells by affimty purifcation using L243-coupled CNBr-actlvated Sepharose (Pharmacla, Milton Keynes, UK), essentially as described before (23) . The complexes were eluted with 25 mM Na2COj, 0.15 M NaCL, 0.1% CI2G,, and (1.1 mM PMSF, pH 11, neutralized with 50 mM Tris-HC1, pH 8.4, followed by buffer exchange for PBS containing either NP-40 or CleE,~.
Peptide Dissociation Assay. The dissociation rates of blotinylated peptldes from DR3 were measured essentially as described (24, 25) using affimty-punfied HLA-DR3 molecules (25, 26) . In brief, DR3 complexes were preloaded with 2 [I,M blotlnylated peptldes for 3 d (37°C, pH 4.5) in binding butter containing 0. l% NP-4i) or C12E,~, pH 4.5. Excess pepndes were removed by 10-K ultrafiltratlon (Amlcon Corp.). The time course of peptlde dissociation from the preloaded DR3 complexes was determined during 48 h at 37°C in binding buffer using 10 nM of D R 3 complexes in the presence or absence ofS0 nM sDM and an excess of 50 FtM unlabeled ApoB(2877-2894) ( Table 1) . MHC-peptlde complexes were imnmnoprecipltated with immobilized L243 and pepndes were detected via streptavtdm and biotmylated peroxldase (24, 25) . The absorbance at 405 nm was measured by an ELISA reader (Multlskan Plus, Titertek, Meckenhelm, Germany) and nonspeclfic signals (quadruplicates, typically 15% of maximal absorbance) were subtracted from the data.
SDS-PAGE, Native PAGE, and IVestern Blot Analysis. SDS-
PAGE of purified sDM was perfbrmed on 12.5% polyacrylamlde gels after boiling of the samples for 5 mira in reducing Laemmh sample buffer. For native PAGE analysis, samples were incubated in non-reducing sample buffer for 30 mm at room temperature. Western blot analyses were pertbrmed as described (21) .
Results and Discussion
T o study the function o f H L A -D M independent from any associated proteins, recombinant soluble D M (sDM) was generated using a baculovlrus expression system. T h e recombinant matenal was purified via a His-tag attached to the DM13 chain, using metal chelate affinity chromatography. T h e purity and composition o f the isolated c o m p l e x was assessed by S D S -P A G E and Western blot analyses. T h e isolated product was highly pure in that it consisted solely o f two proteins with apparent molecular masses o f 28kD and 29kD (Fig. l, C and B) that were c o n f i m l e d to be DM0~ and DM13 chains, respectively, using D M a and DM13-His-tag-specific mAbs (Fig. 1, a and 13) . Native P A G E demonstrated that the sDM was secreted as a heterodimertc Table 1 ). Exchange of NP-40 for CI2E9 In the assays did not change the outcome of the expenments, indicating that the findings were not due to the use of 0.1% NP-40 m the assay.
complex, recognized by both the DMot and DM[3 antibodies, without any detectable aggregation.
The efficacy of sDM was tested by studying its catalytic effect on peptide exchange on DR3 in an in vitro peptide dissociation assay using DR molecules isolated from the DM-negative cell line T2.DR3 (8) . In this cell line, DR3 is almost exclusively associated with CLIP facilitating loading of exogenous peptides onto the D1K molecules because of the high spontaneous disssociation rates of endogenously bound CLIP. Recombinant sDM catalyzed the dissociation of CLIP from CLIP-DR3 complexes (Fig. 2 A) , confirming the results ofSloan et al. (19) . The catalytic effect could still be measured when sDM was applied in substoichiometric amounts compared with DR (1:3 ratio) and with an pH optimum for catalysis ranging between 4.5-5.5 (data not shown).
It is possible that the CLIP-DR complex is a preferential substrate for DM because of specific features of CLIP. The NH~-terminal extension of the CLIP peptide extending from the peptide-binding groove of D1k (residues 81-89) has been implicated in self-release of CLIP from DR (27, 28) . To investigate whether this extension helped peptide release by DM we preloaded D1K3 molecules with either CLIP(81-104) or CLIP(89-101), lacking the extension but containing the complete groove binding region (Table 1) , and studied the dissociation rates of these peptides from DR3 with or without DM. In the absence of DM the dissociation of CLIP(81-104) was faster than that of CLIP(89-101) (tl/2 ~6.25 and 18 h, respectively). The catalytic function of DM was indiscriminate and dissociation rates for both peptides were dramatically increased (tl/,-~0.16 and 1.25 h, respectively) (Fig 2, A and B) . Thus, in this assay, the general mechanism underlying the catalytic action of DM on CLIP dissociation is not dependent on the NH2-terminal extension of CLIP. Moreover, DM-enhanced release of CLIP(81-104) was independent of the presence of excess CLIP(81-92) added in trans (data not shown), suggesting that DM does not interact with CLIP(81-92) to exert its catalytic function. Taken together with the crystallographic data on the CLIP-DR complex (7), our findings imply that there are no obvious features of the CLIP-DR complex to single it out as a substrate for DM in the cellular pool of peptide-class II complexes.
To determine why only some peptide-MHC complexes are substrates for DM (17), we considered which other factors could play a role in the process of DM-mediated peptide dissociation from DR. The interaction between peptides and class II molecules is determined by the DR groove and the primary sequence of the peptide. For natural ligands, the core of the peptide contains allele-specific contact sites that are used as anchonng residues to the class II groove. Conventional antigens found associated with HLA-DIK3 typically contain a hydrophobic/aromatic amino acid three to four residues from the NH2 terminus (at relative position 1; P1), a similar residue at P9, an aspartate forming the Dlk3-specific contact site at P4, and a polar auxiliary anchor at P6. All of these residues anchor in complementary pockets in Dt<3 (23, 25) . In the case of CLIP, the DR-binding motif IS designed for promiscuous binding to different class II alleles via hydrophobic residues at Pl and P9. No allele-specific contact sites are present, since these could jeopardize binding to other class II molecules (7, 29) . The DM sensitivity of the ot[~CLIP complex may be a reflection of this difference in binding motif and thus DM-mediated peptide release might depend on the degree of optimal interactions between peptide and DR-binding groove.
To test this hypothesis, peptide dissociation studies were performed using a range of CLIP variants and antigenic peptides together with derivatives modulated at DR3 anchoring positions (Table 1) . Introduction of the DR3-specific anchor Asp in CLIP(81-104) at P4 led to a stable complex between peptide and DR (hi2 >>48 h) that was no longer sensitive to release by DM (Fig. 3 A) . Substitution of PrOll 2 at P6 for the anchonng residue Lys in CLIP(89-101), containing the minimal groove binding region, resulted only in a minor increase in stability of the peptide-DR complex (h/2 ~22 h) (Fig. 3 B) . Addition of DM still led to a release of the peptide (h/2 ~-3 h) (Fig. 3 B) , but only half as efficiently as the unsubstituted CLIP(89-101) (Fig. 4) . Introduction of anchoring residues at both P4 and P6 generated a stable CLIP-DR complex, and now DM was no longer able to induce dissociation of the peptide (see Fig. 3 B) . Conversely, substitution of the DR3-specific anchor Asp2884 for Ala at P4 in the natural ligand ApoB(2877-2894) (Table 1) , enhancing spontaneous dissociation of the peptide from the DR complex, made the previously insensitive complex highly vulnerable to the catalytic action of DM (see Fig. 3 C) . The HAChlKot(312-325) and MOMP(251-265) peptides bind DR3 with a high binding capacity (6, 19, 25) , but contain suboptimal anchoring residues in some positions with HAChRot(312-325) containing the least optimal binding motif ( Table 1) Table 1 ) on sDM-catalyzed peptide &ssoc]atmn from DP,3 (B) Dissociation of ApoB (2877-2894) with and without the DR3-speclfiC anchor Asp at P4 (Table 1 ) from isolated DP.3 molecules m the presence or absence ofsDM (C). All figures shown are derived from one representative experiment out of five mdiwdual experiments.
DR3 was low, but faster for HAChRot(312-325) than for MOMP(251-265) (Fig. 4) . The dissociation rate of HAChRot(312-325) from DR`3 was sensitive to DM catalysis, whereas the more stable MOMP-DI<3 complex was mostly resistent to the action of DM (Fig. 4) . Since the HAChR`~(312-325) peptide contains an Asp at P4, but has suboptimal anchors for the other contact sites, and MOMP (251-265) lacks the Asp, but otherwise contains an optimal binding motif, these peptides show that the DM sensitivity of peptide-DR`3 complexes was not solely dependent on the absence or presence of the DR3-specific anchor. Taken together, the data demonstrate that the susceptibility of the peptide-DR.3 complex for DM correlated with the overall number of positive interactions anchoring the peptide to the peptide binding groove of DR (Fig. 4 ; Table 1 ).
In conclusion, the data presented here imply that DM functions as a general catalyst to dissociate peptides bound to DR`3. These data are consistent with the observation of a transient interaction between DM and DR`, irrespective of loading with cognate peptide or CLIP (21) . The primary sequence of the peptide itself seems to be the factor determining whether it can be released by DM. The complement of optimal anchoring residues in the peptide dictates the susceptibility of the complex for DM-mediated peptide release, probably by influencing the stability and free energy of the pepude-DR,3 complex. The composition of the nonanchoring residues in the pepude core, together with the regions flanking the core, may contribute to this process in a more subtle manner.
The consequence of the unrestricted action of DM is that in vivo all peptides bound to DR are submitted to the action of DM. Only the most stably bound peptides, presumably selected by a stochastic process, will remain associated with the class II molecule to be exported to the cell surface for antigen presentation. Thus, DM has an editor function (17) , optimizing presentation of appropriate peptides. One could imagine that peptides containing less optimal anchors also reach the cell surface on DR. when present in h~gh amounts or by having an intermediate offrate. A role of DM may be to reduce presentation of these 
